- New Direction in Health Care
More than six million Americans suffer from chronic wounds each year. As Americans age this number is expected to rise dramatically. Research indicates that older Americans are more prone to wound development and decreased healing efficiency. The US population will increase to 350 million in the next 30 years. Trends project that during this time period, the growth rate of those 65 years and older will increase at five times the growth rate of individuals 64 years and younger.
From a clinical and cost outcome basis (i.e., effective wound healing at affordable costs) majority of the current wound care products do not cater to what today’s patient and market demands. Technology must bridge the gap between patient demand and available health care dollars. We at BioCore are proud to offer state-of-the-art biotechnology products for wound care.
Kollagen™ tissue regeneration and wound care products are FDA approved.
